XPEL - Xpel Inc Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Xpel Inc (XPEL)

Other Ticker:

Sector • Basic Materials Industry • Chemical Manufacturing

Industry • Chemical Manufacturing

Sector • Basic Materials

Price: $23.1500 $-0.88

-3.662%

Day's High:	$23.8141	Week Perf:	-11.81 %
Day's Low:	$ 22.85	30 Day Perf:	-8.82 %
Volume (M):	106	52 Wk High:	$ 30.29
Volume (M$):	$ 2,459	52 Wk Avg:	$15.29
Open:	$23.66	52 Wk Low:	$7.50

XPEL Charts & Quotes

XPEL Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	639
Shares Outstanding (Millions)	28
Employees	-
Revenues (TTM) (Millions $)	34
Net Income (TTM) (Millions $)	3
Cash Flow (TTM) (Millions $)	41
Capital Exp. (TTM) (Millions $)	3

Xpel Inc

Company Address: 618 W. Sunset Road San Antonio 78216 TX
Company Phone Number: 678-3700 Stock Exchange / Ticker: NASDAQ XPEL

Xpel Inc 's Segments

• View Complete Report

News

Veritec Inc

Profitability not Reached Despite Strong Sales

Veritec Inc announced earnings per share of $-0.01 and Sales of $0.12 millions in the fourth quarter, Company's lost money per share, versus $-0.01 eps, earned in the same quarter a year ago, although Veritec Inc saw it's Sales rise by 18.87% in the same period.

American Bio Medica Corp

American Bio Medica Corp announced second quarter operating income of $0.016 millions

In the second quarter American Bio Medica Corp reached break-even of $0.00 per share compared to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales grew strongly by 83.51% to $1.76 millions from $0.96 millions in the same quarter a year ago and sequentially Sales doubled by 141.15 % from $0.73 millions.

Fedex Corporation

Strong Eps Underlines Double Digits Sales Growth

For the first quarter earnings jumped by 66.2 % to $4.72 per share, followed by Sales increase of 13.33% to $19.32 billions, compared with the prior year period.

Oracle Corporation

Sales and Profits Increased

Oracle Corporation reported moderate Sales growth of 2.06% to $18.01 billions in the first quarter, eps grew by 14.29 % to $0.72 year on year.

Amag Pharmaceuticals inc

Earnings helped by tax benefit

A $0.16 million tax benefit, helped Amag Pharmaceuticals Inc to post $-0.39 eps in the second quarter

XPEL's Valuation	Current
Price to Earnings PE Ratio (TTM)	262.86
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	18.75
Price to Sales (Expected)	-
Price to Book	16.22
PEG (TTM)	-

XPEL's Financial Strength	Current
Quick Ratio	1.35
Working Capital Ratio	2.61
Leverage Ratio (MRQ)	0.73
Total Debt to Equity	0.19
Interest Coverage (TTM)	29.25
Debt Coverage (TTM)	1.35

Per Share	Current
Earnings (TTM)	0.09 $
Revenues (TTM)	1.23 $
Cash Flow (TTM)	1.47 $
Cash	0.93 $
Book Value	1.43 $
Dividend (TTM)	0 $

XPEL's Efficiency	Current
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	4.71
Inventory Turnover Ratio (TTM)	6.66
Asset Turnover Ratio (TTM)	0.61

XPEL's Profitability Ratio	Current
Gross Margin	32.79 %
Operating Margin	14.36 %
Net Margin	11.1 %
Net Cash Flow Margin	61.24 %
Effective Tax Rate (TTM)	18.27 %

Management Effectiveness	Current
Return On Assets (TTM)	4.61 %
Return On Investment (TTM)	6.06 %
Return On Equity (TTM)	7.4 %
Dividend Yield	-
Payout Ratio (TTM)	-

XPEL's Valuation
Price to Earnings PE Ratio (TTM)	262.86
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	18.75
Price to Sales (Expected)	-
Price to Book	16.22
PEG (TTM)	-

XPEL's Financial Strength
Quick Ratio	1.35
Working Capital Ratio	2.61
Leverage Ratio (MRQ)	0.73
Total Debt to Equity	0.19
Interest Coverage (TTM)	29.25
Debt Coverage (TTM)	1.35

Per Share
Earnings (TTM)	0.09 $
Revenues (TTM)	1.23 $
Cash Flow (TTM)	1.47 $
Cash	0.93 $
Book Value	1.43 $
Dividend (TTM)	0 $

• View Valuation Comparisons

• View Growth Rates Comparisons

XPEL's Efficiency
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	4.71
Inventory Turnover Ratio (TTM)	6.66
Asset Turnover Ratio (TTM)	0.61

XPEL's Profitability Ratio
Gross Margin	32.79 %
Operating Margin	14.36 %
Net Margin	11.1 %
Net Cash Flow Margin	61.24 %
Effective Tax Rate (TTM)	18.27 %

Management Effectiveness
Return On Assets (TTM)	4.61 %
Return On Investment (TTM)	6.06 %
Return On Equity (TTM)	7.4 %
Dividend Yield	-
Payout Ratio (TTM)	-

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar ACBM's Profile Stock Price ACBM's Financials Business Description Fundamentals Charts & Quotes ACBM's News Suppliers ACBM's Competitors Customers & Markets Economic Indicators ACBM's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

XPEL Company Profile

Profitability not Reached Despite Strong Sales

American Bio Medica Corp announced second quarter operating income of $0.016 millions

Strong Eps Underlines Double Digits Sales Growth

Sales and Profits Increased

Earnings helped by tax benefit